<sub id="d1nvr"><font id="d1nvr"><dfn id="d1nvr"></dfn></font></sub>

    <address id="d1nvr"></address>

    <b id="d1nvr"><cite id="d1nvr"><ruby id="d1nvr"></ruby></cite></b><video id="d1nvr"></video>

    <form id="d1nvr"><var id="d1nvr"><address id="d1nvr"></address></var></form>

    <meter id="d1nvr"></meter>

    <form id="d1nvr"></form>

      COMPANY NEWS
      Admission of Product to the PRC National Drug List for Reimbursement, Beifuxin Newly Listed and the Other Three Products Remain on the List
      2019.08.21 Download
      Hong Kong, 21 August 2019

      Essex Bio-Technology Limited (“EssexBio” or the “Group”, Stock code: 1061) today is pleased to announce that Recombinant Bovine Basic Fibroblast Growth Factor (rb-bFGF) Gel (Product series: Beifuxin) has been newly admitted to the latest National Drug List for Basic Medical Insurance, Work Related Injury Insurance and Maternity Insurance (“NDL”) issued by National Healthcare Security Administration and the Ministry of Human Resources and Social Security of the People’s Republic of China on 20 August 2019, whilst the other three bio-pharmaceutical products that were previously included in 2017 NDL remain to be listed.

      Details of the Group’s listed bio-pharmaceutical products are set out below:
      Product series Product form Common name Status
      Beifushu Eye Drops recombinant bovine basic fibroblast
      growth factor (rb-bFGF)
      Class B (No. 444)
      Beifushu Eye Gel recombinant bovine basic fibroblast
      growth factor (rb-bFGF)
      Class B (No. 444)
      Beifuji Lyophilized Powder recombinant bovine basic fibroblast
      growth factor (rb-bFGF)
      Class B (No. 447)
      Beifuxin Gel recombinant bovine basic fibroblast
      growth factor (rb-bFGF)
      Class B (No. 447)

      The Board of Directors believe that the inclusion of Beifuxin, the largest turnover contributor of the Company, into NDL will further accelerate the expansion of distribution network of the Group’s flagship bio-pharmaceutical products in PRC and provide a strong impetus for organic growth in the immediate future.
      This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
      免费看男生裸体自慰_韩国公和熄2_黑帽门7分40视频_男同志FREEVOIDEOS免费